levels, and alleviated ferroptosis under oxidative stress. GABARAPL2 upregulated ACSL3 expression, which further promoted autophagy and inhibited ferroptosis. Autophagy inhibition reversed these protective effects, indicating that GABARAPL2/ACSL3-mediated autophagy plays a key role in mitigating ferroptosis and oxidative stress. GABARAPL2/ACSL3 improves VEC aging and injury by promoting protective autophagy and reducing ferroptosis, thereby improving cellular viability under oxidative stress. These findings offer a potential therapeutic target for diseases associated with endothelial dysfunction.